Soluble α-klotho as a novel biomarker in the early stage of nephropathy in patients with type 2 diabetes.
OBJECTIVE: Although α-klotho is known as an anti-aging, antioxidant, and cardio-renal protective protein, the clinical implications of soluble α-klotho levels in patients with diabetes have not been evaluated. Therefore, this study evaluated whether plasma and urinary α-klotho levels are associated...
Main Authors: | Eun Young Lee, Sang Soo Kim, Ji-Sung Lee, In Joo Kim, Sang Heon Song, Seung-Kuy Cha, Kyu-Sang Park, Jeong Suk Kang, Choon Hee Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4118846?pdf=render |
Similar Items
-
Soluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathy
by: Yong Chul Kim, et al.
Published: (2018-08-01) -
Role of Klotho in Chronic Calcineurin Inhibitor Nephropathy
by: Kang Luo, et al.
Published: (2019-01-01) -
Soluble α-Klotho Serum Levels in Chronic Kidney Disease
by: Silverio Rotondi, et al.
Published: (2015-01-01) -
Soluble klotho as a marker of renal fibrosis and podocyte injuries in human kidneys.
by: Nam-Jun Cho, et al.
Published: (2018-01-01) -
The Organ Handling of Soluble Klotho in Humans
by: Daniela Picciotto, et al.
Published: (2019-08-01)